Swine Flu Epidemic Solution
May 1, 2009 | San Diego, California | Vetting explained
Brian Jovanovic, CEO of Bovis Pharmaceuticals, LLC, discusses viral compound BOV-23, which the company says has shown effectiveness against other influenza viruses in vivo animal tests. Bovis is optimistic that BOV-23 will be effective against the new swine flu influenza virus.
- Tags:
- science,
- swine_flu,
- technology
- Posted in Assignment:
- Tech talk
iReport welcomes a lively discussion, so comments on iReports are not pre-screened before they post. See the iReport community guidelines for details about content that is not welcome on iReport.
What is iReport?
-
Share
Tell a story, offer an opinion, say what's important to you.
-
Discuss
Join the conversation on the day's big issues.
-
Be heard
The best iReports get vetted and used on CNN platforms.
The label “Not vetted by CNN” lets you know that this story hasn’t been both checked and cleared by a CNN editor.
iReport stories that have a red "CNN iReport" stamp in the corner have been vetted and
cleared. That means they've been selected and approved by a CNN producer to use on CNN,
on air, or on any of CNN's platforms.







Comments